Showing 4291-4300 of 7638 results for "".
- Aclaris Therapeutics' A-101 Achieves Positive Results in Clinical Trial for Seborrheic Keratosishttps://practicaldermatology.com/news/aclaris-therapeutics-a-101-achieves-positive-results-in-clinical-trial-for-seborrheic-keratosis/2458989/Aclaris Therapeutics, Inc.’s lead drug candidate A-10 demonstrated clinically and statistically significant improvements in removing seborrheic keratosis (SK) lesions on the face in its third Phase II clinical trial. The double-blind, vehicle-controlled Phase 2 clinical trial was designed to evalua…
- Nanotechnology Study Offers New Direction for Wound Healing Therapyhttps://practicaldermatology.com/news/nanotechnology-study-offers-new-direction-for-wound-healing-therapy/2458991/A novel nanoparticle technology appears to promote wound healing and has led researchers to a new therapeutic target for wound healing, a new study says. Writing in Journal of Investigative Dermatology, the study authors identify the previously uncharacterized microtubule-severing enzyme, Fidgetin…
- Nestlé Skin Health Announces Leadership Teamhttps://practicaldermatology.com/news/nestl-skin-health-announces-leadership-team/2458993/Nestlé Skin Health announced organizational changes at top management level to support the company’s expanded market opportunity and ambition. “Our goal is to grow the number of people the company serves to over a billion within 10 years, by offering skin health solutions that protect, maintain, no…
- L'Oreal International Extends Deadline for Social Responsibility in Dermatology Awardshttps://practicaldermatology.com/news/loreal-international-extends-deadline-for-social-responsibility-in-dermatology-awards/2458996/L’Oréal announced today the extension of the closing date of its International Awards for Social Responsibility in Dermatology to April 15th 2015. Patients with dermatological conditions may frequently face discrimination and feel socially excluded, even children. The International Awards for S…
- Three New CeraVe Baby Products Awarded National Eczema Association Seal of Acceptancehttps://practicaldermatology.com/news/three-new-cerave-baby-products-awarded-national-eczema-association-seal-of-acceptance/2458995/Valeant Pharmaceuticals North America LLC is pleased to announce today that all three products in its newest product line, CeraVe® Baby, have been awarded the National Eczema Association (NEA) Seal of Acceptance™, which maintains rigorous standards for approval. Products include CeraVe® Baby Wash &…
- Novel Anti-Biofilm AQUACEL™ Ag+ Dressing Demonstrates Positive Results in Hard-to-Heal Woundshttps://practicaldermatology.com/news/novel-anti-biofilm-aquacel-ag-dressing-demonstrates-positive-results-in-hard-to-heal-wounds/2458998/A new, multi-country, clinical evaluation study showed that AQUACEL™ Ag+ wound dressing demonstrated positive results in wounds, including those compromised by biofilm and/or infection. AQUACEL™ Ag+ dressings are designed to disrupt biofilm and kill infection-causing bacteria in the wound dressing…
- National Psoriasis Foundation's Patient Registry Begins Recruitinghttps://practicaldermatology.com/news/national-psoriasis-foundations-patient-registry-begins-recruiting/2458999/People with psoriasis and their health care providers will have the opportunity to participate in research that aims to improve treatments and disease outcomes when the first independent U.S. psoriasis registry begins recruiting patients in 2015. The registry, a joint collaboration with the Nationa…
- FDA Clears New 532 nm Laser Delivery System for PicoSure from Cynosurehttps://practicaldermatology.com/news/fda-clears-new-532-nm-laser-delivery-system-for-picosure-from-cynosure/2459001/Cynosure, Inc. received FDA 510(k) clearance of its new 532 nm Laser Delivery System for PicoSure®, creating a powerful, dual-wavelength laser system for removing tattoos of all colors in fewer treatments. PicoSure is widely recognized for its technology leadership, unmatched clinical versatility a…
- Investigational Atopic Dermatitis Cream Disappoints in Phase II Trialhttps://practicaldermatology.com/news/investigational-atopic-dermatitis-cream-disappoints-in-phase-ii-trial/2459003/Results from a phase II trial do not bode well for the future of the investigational atopic dermatitis cream MRX-6. The double-blind, parallel-group, vehicle-controlled study evaluated the safety and efficacy of MRX-6 cream 2% among 73 children suffering from mild-to-moderate atopic dermatitis. Pat…
- derma e® Introduces Scalp Relief Hair Carehttps://practicaldermatology.com/news/derma-e-introduces-scalp-relief-hair-care/2459006/derma e® launched its new Scalp Relief Shampoo and Conditioner. derma e® Scalp Relief Shampoo and Scalp Relief Conditioner work in four therapeutic ways to effectively target scalp problems. The shampoo is designed to cleanse, de-flake, soothe and nourish. The conditioner is designed to detangle, d…